Cargando…
Temozolomide Chronotherapy in Glioma: A Systematic Review
Outcomes for patients with high-grade glioma remain poor. Temozolomide (TMZ) is the only drug approved for first-line treatment of glioblastoma multiforme, the most aggressive form of glioma. Chronotherapy highlights the potential benefit of timed TMZ administration. This is based on pre-clinical st...
Autores principales: | Jia, Jason L., Alshamsan, Bader, Ng, Terry L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955138/ https://www.ncbi.nlm.nih.gov/pubmed/36826108 http://dx.doi.org/10.3390/curroncol30020147 |
Ejemplares similares
-
EVALUATING PNEUMOCYSTIS JIROVECII PNEUMONIA (PCP) PROPHYLAXIS IN PATIENTS WITH GLIOMA RECEIVING CONCURRENT TEMOZOLOMIDE AND RADIATION – A PATIENT AND PHYSICIAN SURVEY
por: Beltran-Bless1, Ana-Alicia, et al.
Publicado: (2023) -
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
por: Damato, Anna R, et al.
Publicado: (2021) -
Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis
por: Delisle, Megan, et al.
Publicado: (2022) -
Resistant Hypertension and Chronotherapy
por: Prkacin, Ingrid, et al.
Publicado: (2015) -
Chronobiology and Chronotherapy of Osteoporosis
por: Winter, Elizabeth M, et al.
Publicado: (2021)